Skip to main content
1717 results

Certara Announces Inaugural Client Conference with Keynote by Dr. Scott Gottlieb 

Agenda features discussion of life sciences industry trends, business value of model-informed drug development strategies, and impact of generative AI on biosimulation and regulatory sciences    RADNOR, PA– April. 18, 2024 – Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that it will host the first-ever Certainty Conference. At this event, … Continued

https://www.certara.com/announcement/certara-announces-inaugural-client-conference-with-keynote-by-dr-scott-gottlieb/

The Challenges and Opportunities of Rare Disease Drug Development

New therapeutics development in rare diseases presents both opportunities and complexities. Because of the small patient pool available in these indications, there are challenges in designing and conducting clinical trials and the data interpretation that follows, and the ultimate path to registration. The top 3 critical downfalls in rare diseases development include Poor understanding of … Continued

https://www.certara.com/white-paper/the-challenges-and-opportunities-of-rare-disease-drug-development/

Pinnacle 21 demo

Build Validated Studies Up To 85% Faster: With Pinnacle 21 See how to achieve faster drug development, with less effort, and less manual work. The Pinnacle 21 software suite augments your capabilities – helping you quickly build validated studies, get cleaner vendor data (minus the delays), automate SDTM, and speed time-to-analysis. Powered by technology, you’ll … Continued

https://www.certara.com/pinnacle-21-enterprise-software/demo/

Certara Launches Cloud Platform to Further Unify its End-to-End Scientific Software Platform

PRINCETON, NJ – April 16, 2024 – Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced the launch of Certara Cloud, the unifying platform that integrates its many scientific software solutions. Customers log into Certara Cloud using a single ID to access and manage their licensed software, linking predictive solutions to … Continued

https://www.certara.com/pressrelease/certara-launches-cloud-platform-to-further-unify-its-end-to-end-scientific-software-platform/

Certara Announces New Corporate Headquarters

New, spacious location in Radnor, Pennsylvania will support the needs of company’s growing workforce and business, strengthen presence in the state RADNOR, PA – April 15, 2024 – Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced the relocation of its corporate headquarters to Radnor, Pennsylvania. The new headquarters is 13 … Continued

https://www.certara.com/announcement/certara-announces-new-corporate-headquarters/

What are biosimilars & how are they developed?

Learn about biosimilars, their benefits for patients who take biologic drugs, and how pharmaceutical companies demonstrate their bioequivalence to approved biosimilars.

https://www.certara.com/blog/what-are-biosimilars-how-are-they-developed/

Chemicals

The chemicals industry has achieved remarkable innovations in various areas such as biodegradables, advanced battery materials, sustainable green energy solutions and additives to make carbon reduction processing in industrial uses. They are focused on recombining nature’s molecules to invent exciting new things and refine applications for existing products and components (as stated by Joshua Greenbaum, … Continued

https://www.certara.com/chemicals/

Enhancing Regulatory Writing: The Power of Style Guides

TranscriptMany pharmaceutical industry professionals once considered standardizing regulatory writing style conventions unnecessary and time-consuming. However, the industry now recognizes its benefits for maximizing efficiency during regulatory submission development.  The benefits of using style guides and lexicons in medical writing include:  The Certara Drug Development Solutions Document Quality group is experienced in creating and maintaining style guides and … Continued

https://www.certara.com/video/enhancing-regulatory-writing-the-power-of-style-guides/

Molecular Glue Drug Development Summit 2024 Recap

Transcript: Hello, and welcome to Certara Talks. I’m Doctor Suzanne Minton, and I’m a director of content strategy at Certara . Today, I’m talking to my colleague, doctor Joshua Apgar. Joshua, welcome to Certara talks. Would you like to introduce yourself? Sure. Thank you. I’m, Josh Apgar, one of the co founders at applied Balmain, … Continued

https://www.certara.com/video/molecular-glue-drug-development-summit-2024-recap/
1 of 172